BrainPharm: Pathological mechanism

	Name
1	Abeta inhibits nicotinic ACh receptors at pre-synaptic glutamatergic terminals
2	AD combined treatment with cholinesterase inhibitor and alpha-adrenergic agonist.

This database was supported by the Human Brain Project (NIDCD, NIMH, NIA, NICD, NINDS) and MURI (Multidisciplinary University Research Initiative). It is now supported by RO1 DC 009977 from the National Institute for Deafness and other Communication Disorders.

Questions, comments, problems? Email the Brain Pharm Administrator
This site is Copyright @1998-2023 Shepherd Lab, Yale University

Pathological mechanism (s) having Acetylcholine as Transmitter(s)